Evogene Ltd. (NASDAQ:EVGN)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as $3.50 and last traded at $3.74, with a volume of 4800 shares trading hands. The stock had previously closed at $3.78.
A hedge fund recently raised its stake in Evogene stock. Vanguard Group Inc. increased its stake in shares of Evogene Ltd. (NASDAQ:EVGN) by 4.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 436,225 shares of the biotechnology company’s stock after acquiring an additional 17,391 shares during the quarter. Vanguard Group Inc. owned about 1.70% of Evogene worth $2,443,000 at the end of the most recent reporting period. 30.99% of the stock is currently owned by institutional investors.
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.
Receive News & Ratings for Evogene Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.